Aspro Mershen Govender

Mershen Govender is a pharmaceutical scientist whose work centers on advanced drug delivery systems and biomaterials for targeted and sustained therapeutic applications. Research spans pulmonary delivery of labile bioactives, intrauterine and intravaginal platforms for menopausal conditions, and gastroretentive systems for narrow-absorption drugs. Emphasis is placed on rational polymer design, controlled release kinetics, and overcoming physiological barriers to improve bioavailability and safety.

A strong focus on women’s health is evident through the development of estrogen- and progestin-loaded intrauterine and vaginal devices for genitourinary syndrome of menopause, integrating polymer engineering with cytocompatibility and permeation studies. Contributions also extend to oncology, including pH-responsive nanocarriers for paclitaxel and nano-enabled strategies to enhance tyrosine kinase inhibitor efficacy, highlighting expertise in nanomedicine and tumor-targeted delivery.

Scholarly reviews and book chapters on polyurethanes, nanoscale vaccines, and 3D bioprinted microneedles demonstrate leadership in biomaterials and regenerative medicine. Across publications, key strengths include formulation optimization, mechanistic modeling of drug release, and translation-oriented design of multifunctional platforms that bridge materials science and therapeutic innovation.